Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	925.01	1,010	985.62	688.77	446.2	445.87
Trading Asset Securities	107.23	58	115.17	340.55	581.01	580.43
Cash & Short-Term Investments	1,032	1,068	1,101	1,029	1,027	1,026
Cash Growth	-10.08%	-3.02%	6.94%	0.21%	0.09%	-1.98%
Accounts Receivable	205.54	189.28	161.69	154.55	93.52	135.81
Other Receivables	3.55	4.28	2.44	3.47	3.68	1.65
Receivables	209.1	193.56	164.14	158.02	97.2	137.46
Inventory	146.11	129.35	126.33	135.93	196.96	99.45
Other Current Assets	22.51	16.12	13.78	18.06	17.46	7.11
Total Current Assets	1,410	1,407	1,405	1,341	1,339	1,270
Property, Plant & Equipment	152.74	151.71	157.72	143.24	137.33	94.48
Other Intangible Assets	21.15	21.57	20.43	21.07	22.06	22.54
Long-Term Deferred Tax Assets	10.69	11.18	8.45	9.27	10.21	7.67
Long-Term Deferred Charges	-	-	0.88	0.69	0	0.13
Other Long-Term Assets	7.89	3.84	4.49	6.89	5.5	2.94
Total Assets	1,602	1,595	1,597	1,522	1,514	1,398

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	93.09	75.6	68.32	66.91	92.09	53.89
Accrued Expenses	13.62	31.99	33.12	32.09	36.98	32.75
Current Portion of Leases	-	1.28	3.86	4.02	0.31	0.58
Current Income Taxes Payable	8.67	7.69	6.59	3.26	2.15	3.84
Current Unearned Revenue	23.94	31.09	30.7	16	22.99	25.21
Other Current Liabilities	72.7	48.34	24.19	16.11	33.94	23.45
Total Current Liabilities	214.13	195.99	166.79	138.39	188.47	139.73
Long-Term Leases	3.7	1.86	2.67	6.32	5.8	0.79
Long-Term Unearned Revenue	0.95	0.22	0.81	2.3	1.85	3.54
Long-Term Deferred Tax Liabilities	-	-	-	-	0.15	-
Other Long-Term Liabilities	15.6	13.36	6.16	6.41	4.15	8.43
Total Liabilities	234.39	211.43	176.42	153.42	200.42	152.49

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	112.13	112.13	112.12	112.12	112.12	80
Additional Paid-In Capital	899.85	899.04	903.81	905.22	907.56	937.6
Retained Earnings	387.96	384.03	413.05	362.04	294.05	228.2
Treasury Stock	-	-	-10.09	-10.09	-	-
Comprehensive Income & Other	-31.89	-11.71	1.7	-0.22	-0.22	-0.22
Shareholders' Equity	1,368	1,383	1,421	1,369	1,314	1,246
Total Liabilities & Equity	1,602	1,595	1,597	1,522	1,514	1,398

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.81	3.14	6.53	10.34	6.11	1.37
Net Cash (Debt)	1,026	1,064	1,094	1,019	1,021	1,025
Net Cash Growth	-10.17%	-2.72%	7.39%	-0.21%	-0.37%	-2.11%
Net Cash Per Share	9.21	9.50	9.81	9.25	9.07	9.11
Filing Date Shares Outstanding	110.18	112.13	111.87	112.12	112.12	112
Total Common Shares Outstanding	110.18	112.13	111.87	112.12	112.12	112
Working Capital	1,196	1,211	1,238	1,203	1,150	1,131
Book Value Per Share	12.42	12.34	12.70	12.21	11.71	11.12
Tangible Book Value	1,347	1,362	1,400	1,348	1,291	1,223
Tangible Book Value Per Share	12.22	12.15	12.52	12.02	11.52	10.92
Buildings	-	73.26	73.38	73.28	67.53	66.75
Machinery	-	83.13	81.95	75.2	71.87	67.29
Construction In Progress	-	79.79	76.3	55.56	52.33	8.65

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error